Skip to main content
SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD logo

SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000078 ISIN · CNE000000X95 LEI · 300300J4GCOV7CYQTB51 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,614 across all filing types
Latest filing 2025-09-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000078

About SHENZHEN NEPTUNUS BIOENGINEERING CO.,LTD

https://www.neptunusbio.com

Shenzhen Neptunus Bioengineering Co., Ltd. is a comprehensive healthcare enterprise focused on the research, development, manufacturing, and distribution of pharmaceutical products. The company operates across the entire industry value chain, including the production of chemical drugs, biological preparations, and traditional Chinese medicines. Its portfolio extends to medical devices and health supplements. A significant component of its operations involves a large-scale pharmaceutical distribution network and a nationwide retail pharmacy chain. The company emphasizes innovation in biotechnology and maintains modern production facilities to support its diverse product lines. By integrating R&D with a robust logistics and retail infrastructure, it provides a wide range of healthcare solutions to medical institutions and consumers.

Recent filings

Filing Released Lang Actions
独立董事候选人关于参加最近一次独立董事培训的承诺书
Regulatory Filings Classification · 95% confidence The document is a short commitment letter from an independent director candidate regarding participation in a training and obtaining a qualification certificate. It is not a financial report, regulatory filing, or announcement of voting results. It does not fit into categories like Annual Report, Audit Report, or Management Information. It is a regulatory announcement related to corporate governance but does not detail governance structure or rules. Given its nature as a formal commitment related to director qualifications, it best fits under Regulatory Filings (RNS) as a miscellaneous regulatory announcement.
2025-09-29 Chinese
关于召开2025年第二次临时股东会通知的公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2025 second extraordinary general meeting (临时股东会) of Shenzhen Haier Bioengineering Co., Ltd. It includes information about the meeting date, voting procedures (including cumulative voting for board elections), proposal details, registration methods, and proxy authorization forms. The content focuses on the organization and conduct of a shareholders' meeting, including board member elections and amendments to company rules. There is no financial data, earnings information, or audit content. The document is not a report itself but an official notice about the meeting and voting process. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice about the meeting and voting procedures rather than the results or solicitation materials, it aligns best with Proxy Solicitation & Information Statement (PSI).
2025-09-29 Chinese
预算委员会工作细则（2025年9月）
Governance Information Classification · 95% confidence The document is titled as the "Budget Committee Working Rules" of the Board of Directors of Shenzhen Haier Bioengineering Co., Ltd. It details the structure, responsibilities, meeting procedures, and confidentiality obligations of the budget committee under the board. There is no financial data, no report of financial results, no announcement of voting results, no legal proceedings, no capital changes, no earnings data, and no investor presentation. The document is a governance-related internal regulation outlining committee rules and procedures, which fits the category of Governance Information (CGR). The document length is 3382 characters, which is relatively short but contains substantive governance content rather than a mere announcement. Therefore, the best classification is Governance Information (CGR).
2025-09-29 Chinese
薪酬与考核委员会工作细则（2025年9月）
Remuneration Information Classification · 95% confidence The document is a detailed set of rules and procedures for the Remuneration and Assessment Committee of the Board of Directors of Shenzhen Haier Bioengineering Co., Ltd. It outlines the committee's composition, responsibilities, meeting procedures, and authority related to executive compensation and performance evaluation. It is not a financial report, earnings release, or announcement of voting results. It is a governance-related document focusing on compensation policies and committee operations, which fits the definition of Remuneration Information filings.
2025-09-29 Chinese
内幕信息知情人登记管理制度（2025年9月）
Governance Information Classification · 95% confidence The document is titled as an "Insider Information Insider Registration Management System" for Shenzhen Haier Bioengineering Co., Ltd., revised in September 2025. It details the company's internal policies and procedures for managing insider information, including definitions of insider information, scope of insider persons, registration and record-keeping requirements, confidentiality obligations, and responsibilities. The document includes regulatory references to Chinese securities laws and Shenzhen Stock Exchange rules. It is a governance and compliance policy document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement or a certification. The content aligns with internal governance and compliance practices related to insider information management. Therefore, the most appropriate classification is Governance Information (CGR).
2025-09-29 Chinese
关联交易管理制度（2025年9月修订草案）
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' (Related Party Transaction Management System) and is a detailed internal policy document of Shenzhen Haier Bioengineering Co., Ltd. It outlines principles, scope, procedures, and responsibilities regarding related party transactions. It references relevant laws and stock exchange rules but does not contain financial statements, audit results, or report data. It is a governance-related internal rules document rather than a financial report, announcement, or regulatory filing. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and contains substantive content, not a brief announcement or certification.
2025-09-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.